New research reveals UBX1325's potential to significantly improve vision in diabetic macular edema patients, offering hope ...

The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

The following is a summary of “Recent advances and applications of optical coherence tomography angiography in diabetic ...

The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the ...